Ruger vs. Beretta: A Proxy War Erupts in the Firearms Industry
- Beretta holds a 9.95% stake in Ruger, escalating tensions with demands for a 25% ownership stake and board representation.
- Ruger’s net income has dropped over 90% from its peak to a decade low.
- Ruger’s stock jumped 2.4% following Beretta’s board nominations.
Experts would likely conclude that this proxy battle highlights the tension between shareholder activism and corporate defense, with significant implications for Ruger’s independence, industry consolidation, and national security.
Ruger vs. Beretta: A Proxy War Erupts in the Firearms Industry
MAYODAN, NC – March 09, 2026 – A tense corporate showdown is escalating between two of the world's most recognized firearms manufacturers, as American gunmaker Sturm, Ruger & Company (NYSE: RGR) has publicly accused Italian arms giant Beretta Holding S.A. of orchestrating a “creeping takeover.” The conflict ignited after Beretta, Ruger’s largest single shareholder, announced its intention to nominate four new candidates to Ruger’s Board of Directors, a move Ruger has framed as an aggressive campaign to seize control on unfair terms.
In a sharply worded press release, Ruger fired back against Beretta’s maneuver, which it received on February 24, 2026. The American company detailed a months-long struggle, alleging that Beretta engaged in a hostile accumulation of stock while making “extreme demands” that would undermine Ruger’s independence and harm its other stockholders. This public battle pulls back the curtain on a high-stakes fight for the future of a major U.S. manufacturer, raising complex questions about corporate governance, shareholder rights, and national security.
Ruger's Stand Against a 'Creeping Takeover'
Ruger’s leadership claims the confrontation began in September 2025, when Beretta disclosed a 7.7% stake in the company without any prior contact. According to Ruger, subsequent attempts to engage constructively were met with resistance. The company alleges that Beretta refused repeated requests to pause its share accumulation pending discussions, prompting Ruger’s board to adopt a short-term stockholder rights plan—a defensive tactic often called a “poison pill”—on October 14, 2025, to protect against a hostile takeover.
Negotiations that followed were fraught with tension. Ruger claims that during meetings in Paris and Luxembourg, Beretta outlined a long-term plan to combine the two companies but advanced demands that Ruger’s board deemed unacceptable. These allegedly included a request for Ruger to issue new shares to Beretta at a 15% discount, which would dilute the value for existing stockholders. Beretta also purportedly demanded a 25% ownership stake and disproportionate representation on the board, including the appointment of a Beretta management team member.
In its rebuttal, Ruger stated it “repeatedly advanced extreme demands and threatened to ‘go to war’ if those demands were not met.” The American firm contends that Beretta’s proposals were not only financially detrimental but also legally problematic. Granting a direct competitor like Beretta significant board representation would, according to Ruger, “violate U.S. antitrust laws.” Furthermore, the company warned that the level of ownership and control sought by the foreign-owned Beretta would trigger a mandatory review by the Committee on Foreign Investment in the United States (CFIUS), implicating “sensitive national security issues.”
Beretta's Push for Accountability
Beretta presents a starkly different narrative. Casting itself as an activist investor, the Luxembourg-based holding company, which now holds an approximately 9.95% stake, argues its actions are necessary to address “sustained shareholder value destruction” at Ruger. Through its campaign website, ReloadRuger.com, Beretta has laid out a case against Ruger's current leadership, citing margin compression, ineffective capital allocation, and strategic missteps.
The Italian firm points to Ruger’s lagging financial performance as evidence of the need for change. Beretta highlights that Ruger’s net income has plummeted by over 90% from its peak to a decade low, and its stock has significantly underperformed against competitors like Smith & Wesson and the broader Russell 2000 index over the last three years. Beretta also criticized the incumbent board for its long tenure and minimal collective ownership of company stock, suggesting a misalignment of interests with shareholders.
To remedy this, Beretta has nominated a slate of four director candidates—Michael Christodolou, William F. Detwiler, Mark W. DeYoung, and Fredrick DiSanto—who it says possess deep industry, financial, and governance expertise. Beretta insists its goal is to install accountability and unlock value for all stockholders, dismissing Ruger’s recent board changes as “inadequate” and purely “reactive” to its own activist pressure.
A Battle Over Governance and Strategy
The clash is also a textbook case of modern corporate defense versus shareholder activism. Ruger’s adoption of a poison pill is a classic defensive maneuver designed to force a potential acquirer to the negotiating table rather than allowing a direct, hostile accumulation of shares. Ruger also points to its recent board refreshment as proof of its proactive governance. On February 23, the company announced three new directors following several retirements, noting that five new directors have joined the board in the past year through what it calls “rigorous and well-established governance processes” that began long before Beretta's investment.
However, Beretta’s ability to nominate its own slate is empowered by modern proxy rules, including the universal proxy card, which allows shareholders to vote for a mix of company and dissident nominees. This has leveled the playing field for activist investors seeking to challenge incumbent boards.
The market has reacted with keen interest. Ruger’s stock saw a 2.4% jump following the news of Beretta’s nominations, suggesting some investors are optimistic that the pressure could lead to positive changes or a potential acquisition premium. However, analyst ratings remain mixed, reflecting the deep uncertainty surrounding the company’s profitability and the outcome of this fight.
Broader Implications for the Firearms Industry
Beyond the boardroom drama, the Ruger-Beretta conflict carries significant implications for the wider firearms industry. A potential combination of two of the sector's largest players would undoubtedly attract intense scrutiny from antitrust regulators. The U.S. Department of Justice and the Federal Trade Commission would have to weigh whether such a consolidation would substantially lessen competition in the handgun and long-gun markets where both companies are major forces.
The national security concerns raised by Ruger are also not trivial. While Beretta is a long-standing company with operations in allied nations, the firearms industry is considered a critical part of the U.S. defense industrial base. Any transaction giving a foreign entity significant influence or control over a major American arms maker like Ruger would face a thorough CFIUS review to assess potential risks.
As both sides prepare to make their case directly to shareholders ahead of Ruger’s 2026 Annual Meeting, the firearms industry watches closely. Ruger's board maintains it is committed to its duties and willing to “engage constructively,” but it has also drawn a clear line in the sand, vowing to protect the company from what it sees as a coercive campaign. Beretta, meanwhile, is pushing forward, determined to force a change in leadership and strategy. The outcome of this proxy war will not only determine the fate of Ruger’s independence but could also signal a new wave of consolidation and activism within a uniquely American industry.
